Artiva Biotherapeutics, Inc. ARTV Accrued Liabilities, Current
Accrued Liabilities, Current at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s accrued liabilities, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s accrued liabilities, current?
- Artiva Biotherapeutics, Inc. (ARTV) reported accrued liabilities, current of $5.56M in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s accrued liabilities, current changed year-over-year?
- Artiva Biotherapeutics, Inc.'s accrued liabilities, current decreased by 12.8% year-over-year, from $6.38M to $5.56M.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s accrued liabilities, current?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s accrued liabilities, current has grown at a 9.4% compound annual growth rate (CAGR), from $8.02M to $9.6M.